查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830892

2025年全球性行为感染感染（STI）及阴道炎聚合酵素链锁反应（PCR）检测市场报告

Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，性行为感染感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场迅速扩张，预计从2024年的6.2亿美元成长到2025年的6.8亿美元，复合年增长率达10.1%。这一增长主要归功于远端医疗平台的扩张、电子健康记录的日益普及、保险覆盖范围的扩大、社区检测倡议的增加以及诊断检测数量的增长。

预计未来几年，性行为感染感染 (STI) 和阴道炎聚合酵素链锁反应(PCR) 检测市场将保持强劲成长，到 2029 年市场规模将达到 9.9 亿美元，复合年增长率 (CAGR) 为 9.8%。预测期内的成长主要归因于全球性行为感染盛行率的上升、阴道感染疾病发生率的增加、育龄人口的成长以及整体人口的成长。预测期内的关键趋势包括技术进步、多重 PCR 检测板的应用、与远端医疗平台的整合、与数位设备的连接以及自采样检测套组的开发。

性行为感染感染（STI）和阴道炎的聚合酵素链锁反应（PCR）检测是一种高度精确的分子诊断技术，它能够扩增和检测引起性行为感染和阴道感染疾病的病原体的遗传物质。此方法可快速识别细菌、病毒和其他微生物，使医疗保健人员能够有效诊断感染疾病并制定个人化治疗方法。

性传染感染和阴道炎PCR检测的主要类型包括性传染感染PCR检测组合和阴道炎PCR检测组合。性传染感染是由细菌、病毒、真菌或寄生虫引起的感染疾病，主要透过性接触传播，包括阴道性交、肛交和口交。这些检测涵盖多种性行为感染感染和阴道感染疾病，并被包括医院/诊所、诊断实验室和家庭护理/居家检测在内的各种终端使用者使用。

美国不断提高的关税以及持续到2025年的贸易紧张局势正对医疗设备行业产生重大影响，尤其是进口诊断成像设备部件、手术用不銹钢和塑料耗材。医院和诊所都在抵制价格上涨，这挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要重新认证设备，从而延缓产品上市时间。企业正透过关键零件的双重采购、扩大国内同质化产品的生产以及加速研发经济高效材料来降低风险。

本研究报告为商业研究公司（The Business Research Company）最新系列报告的一部分，该系列报告提供性行为感染感染（STI）和性行为感染聚合酵素链锁反应聚合酵素链锁反应（PCR）检测行业的市场统计数据，包括全球市场规模、区域份额、性传播感染（STI）和阴道炎聚合酵素链锁反应（性行为感染（STI）和阴道炎聚合酶链反应（PCR）本市场研究报告对该行业的现状和未来发展趋势进行了详细分析，为您提供所需的一切全面观点。

预计未来几年，性健康检测的增加将推动性行为感染感染 (STI) 和阴道炎聚合酵素链锁反应(PCR) 检测市场的成长。性健康检测包括用于检测性传染感染及相关疾病的医学检测，从而实现早期诊断、治疗和预防疾病传播。筛检检测的增加正值全球性传染感染盛行率不断上升之际，凸显了及时检测和治疗对于预防併发症和遏制感染传播的重要性。这些筛检检测对于性传染感染和阴道炎 PCR 检测至关重要，能够早期准确地识别感染，即使是无症状感染者也能被识别，从而支持及时治疗和感染控制。例如，根据英国英国安全局的数据，2023年6月共进行了2,195,909次披衣菌感染、淋病、梅毒或爱滋病毒的性健康筛检服务，比2021年的1,936,455次增加了13.4%。因此，性健康检测的增加正在推动性传染感染和阴道炎PCR检测市场的成长。

性传染感染和阴道炎PCR检测市场的关键参与者正在率先开发创新解决方案，例如多重PCR检测，以提高诊断准确性、缩短检测时间并加快治疗决策。多重PCR检测是一种诊断工具，它利用单次PCR反应即可从单一样本同时检测多种病原体。例如，2022年11月，美国分子诊断公司Cepheid Inc.推出了Xpert Xpress多重阴道病原体检测板（MVP）。这种快速多重PCR检测可从单一阴道样本中检测出三种主要阴道感染病原体—细菌性阴道炎、外阴阴道念珠菌症和滴虫病—的DNA。此检测可在约60分钟内提供结果，有助于对有症状的女性进行更快、更准确的诊断，并有助于标靶治疗，从而减少治疗失败和不必要的抗生素使用。此检测与Cepheid的GeneXpert系统相容，可透过在护理点快速识别併发感染疾病，从而改善临床决策和患者预后。

2022年6月，总部位于德国的检测解决方案开发商R-Biopharm Inc.收购了AusDiagnostics，具体金额未揭露。透过此次收购，R-Biopharm旨在拓展其分子诊断能力，丰富其临床诊断产品组合，进军新的全球市场领域，并巩固其作为值得信赖的系统解决方案提供者的地位，提供更完善的诊断方案。总部位于澳洲的AusDiagnostics生产用于分子诊断综合征检测的体外诊断剂和机器人系统，并提供性传播感染和阴道炎的PCR检测。

性行为感染感染 (STI) 和阴道炎聚合酵素链锁反应(PCR) 检测市场由提供临床咨询、综合筛检、多重检测、治疗监测和检体采集指导等服务的营业单位所获得的收入构成。市场价值还包括服务提供者销售的或包含在其服务中的相关产品的价值。性行为感染感染 (STI) 和阴道炎聚合酵素链锁反应(PCR) 检测市场还包括核酸萃取试剂套件、阳性和阴性对照、自动化 PCR 分析仪以及单病原体 PCR检测套组的销售。该市场的价值为“出厂价”，即产品製造商或创建者销售的产品价值，无论销售对像是其他营业单位（包括下游製造商、经销商、分销商和零售商）还是直接销售给最终客户。该市场的产品价值还包括产品创建者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球性行为感染感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：成长率分析
  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场表现：规模和成长，2019-2024年
  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场预测：规模和成长，2024-2029年，2034年
  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测：潜在市场规模（TAM）

第六章 市场细分

  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：按检测类型、表现和预测划分，2019-2024年、2024-2029年、2034年
  • 性行为感染感染（STI）聚合酵素链锁反应（PCR）检测组
  • 阴道炎聚合酵素链锁反应（PCR）检测组
  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：依病症、表现和预测划分，2019-2024年、2024-2029年、2034年
  • 性行为感染传染病
  • 阴道感染疾病
  • 全球性行为感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：按最终用途、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 医院和诊所
  • 诊断实验室
  • 居家护理或居家检测
  • 其他的
  • 全球性行为感染感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：性行为感染感染（STI）聚合酵素链锁反应（PCR）检测板细分，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 披衣菌感染衣原体聚合酵素链锁反应
  • 淋病奈瑟聚合酵素链锁反应
  • 阴道滴虫炎聚合酵素链锁反应
  • 单纯疱疹病毒聚合酵素链锁反应
  • 人类乳突病毒聚合酵素链锁反应
  • 霉浆菌支原体聚合酵素链锁反应
  • 梅毒聚合酵素链锁反应
  • 多重性行为感染传染病聚合酵素链锁反应检测组
  • 全球性行为感染(STI) 和阴道炎聚合酵素链锁反应(PCR) 检测市场：阴道炎聚合酵素链锁反应(PCR) 检测板细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 细菌性阴道炎聚合酵素链锁反应
  • 念珠菌聚合酵素链锁反应
  • 滴虫病聚合酵素链锁反应
  • 混合型阴道炎聚合酵素链锁反应检测
  • 需氧性阴道炎聚合酵素链锁反应
  • 萎缩性阴道炎聚合酵素链锁反应

第七章 区域和国家分析

  • 全球性行为感染（STI）及阴道炎聚合酵素链锁反应（PCR）检测市场按地区划分、绩效及预测（2019-2024年、2024-2029年、2034年）
  • 全球性行为感染（STI）及阴道炎聚合酵素链锁反应（PCR）检测市场依国家/地区划分、绩效及预测（2019-2024年、2024-2029年、2034年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 性行为感染感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：竞争格局
  • 性行为感染感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：公司概况
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Hologic Inc.
  • QIAGEN NV
  • ARUP Laboratories Inc.
  • Seegene Inc.
  • LetsGetChecked Ltd.
  • Sansure Biotech Inc.
  • Visby Medical Inc.
  • R-Biopharm AG
  • Savyon Diagnostics Ltd.
  • altona Diagnostics GmbH
  • SpeeDx Pty Ltd.
  • CERTEST BIOTEC SL
  • ALPCO Diagnostics
  • Atila Biosystems Inc.
  • Ridacom Diagnostics Ltd.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年性行为感染感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：提供新机会的国家
  • 2029年性行为感染感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：提供新机会的细分市场
  • 2029年性行为感染感染（STI）和阴道炎聚合酵素链锁反应（PCR）检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r37883

Sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing is a highly accurate molecular diagnostic technique that amplifies and detects the genetic material of pathogens responsible for sexually transmitted and vaginal infections. This method allows for rapid identification of bacteria, viruses, and other microorganisms, enabling healthcare providers to diagnose infections effectively and customize treatments.

The primary test types for STI and vaginitis PCR testing include STI PCR panels and vaginitis PCR panels. STIs are infections caused by bacteria, viruses, fungi, or parasites, primarily transmitted through sexual contact, including vaginal, anal, and oral sex. These tests cover a broad spectrum of sexually transmitted and vaginal infections and are used by various end users such as hospitals and clinics, diagnostic laboratories, and homecare or at-home testing services.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market statistics, including sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing industry global market size, regional shares, competitors with a sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market share, detailed sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing industry. This sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market size has grown rapidly in recent years. It will grow from $0.62 billion in 2024 to $0.68 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the expansion of telemedicine platforms, increased adoption of electronic health records, rising insurance coverage, growth in community-based testing initiatives, and a higher number of diagnostic tests being conducted.

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market size is expected to see strong growth in the next few years. It will grow to $0.99 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the increasing global prevalence of sexually transmitted infections, rising incidence of vaginal infections, a growing population of reproductive-age individuals, and overall population growth. Major trends in the forecast period include technological advancements, adoption of multiplex PCR panels, integration with telehealth platforms, connectivity with digital devices, and the development of self-collected testing kits.

The increasing number of sexual health screenings is expected to drive growth in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in the coming years. Sexual health screenings involve medical tests that detect STIs and related conditions, enabling early diagnosis, treatment, and prevention of disease transmission. The rise in screenings is driven by the growing prevalence of STIs worldwide, highlighting the need for timely detection and treatment to prevent complications and limit the spread of infections. These screenings are critical for STI and vaginitis PCR testing, as they allow for early and accurate identification of infections, often even in asymptomatic individuals, supporting prompt treatment and infection control. For example, according to the UK Health Security Agency, a UK-based government body, 2,195,909 sexual health screening services for chlamydia, gonorrhea, syphilis, or HIV were conducted in June 2023, representing a 13.4% increase from the 1,936,455 tests performed in 2021. Consequently, the rise in sexual health screenings is fueling growth in the STI and vaginitis PCR testing market.

Key players in the STI and vaginitis PCR testing market are developing innovative solutions, such as multiplex PCR tests, to improve diagnostic accuracy, reduce testing time, and enable faster treatment decisions. Multiplex PCR tests are diagnostic tools that detect multiple pathogens simultaneously from a single sample using one PCR reaction. For instance, in November 2022, Cepheid Inc., a US-based molecular diagnostics company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP), a rapid multiplex PCR test that detects DNA from the three primary causes of vaginal infections, bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis using a single vaginal sample. Delivering results in approximately 60 minutes, this test supports faster and more precise diagnosis in symptomatic women, facilitating targeted treatments that reduce treatment failures and unnecessary antibiotic use. Compatible with Cepheid's GeneXpert systems, it enhances clinical decision-making and patient outcomes by quickly identifying co-infections at the point of care.

In June 2022, R-Biopharm Inc., a Germany-based developer of test solutions, acquired AusDiagnostics for an undisclosed amount. Through this acquisition, R-Biopharm aims to expand its molecular diagnostics capabilities, broaden its clinical diagnostics portfolio, enter new global market segments, and strengthen its position as a trusted provider of system solutions with enhanced diagnostic options. AusDiagnostics, based in Australia, manufactures in vitro diagnostic reagents and robotic systems for molecular-based syndromic testing, offering PCR testing for STIs and vaginitis.

Major players in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd., Sinochips Diagnostics Co Ltd., Vitassay S.L., and Bioperfectus Technologies Co. Ltd.

North America was the largest region in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in 2024. The regions covered in sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market consists of revenues earned by entities by providing services such as clinical consultations, comprehensive screening tests, multiplex testing, treatment monitoring, and sample collection guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market also includes sales of nucleic acid extraction kits, positive and negative control materials, automated PCR analyzers, and single-pathogen PCR test kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels; Vaginitis Polymerase Chain Reaction (PCR) Panels
  • 2) By Condition: Sexually Transmitted Infections; Vaginal Infections
  • 3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Or At-Home Testing; Other End Users
  • Subsegments:
  • 1) By Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels: Chlamydia Trachomatis Polymerase Chain Reaction; Neisseria Gonorrhoeae Polymerase Chain Reaction; Trichomonas Vaginalis Polymerase Chain Reaction; Herpes Simplex Virus Polymerase Chain Reaction; Human Papillomavirus Polymerase Chain Reaction; Mycoplasma Genitalium Polymerase Chain Reaction; Syphilis Polymerase Chain Reaction; Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
  • 2) By Vaginitis Polymerase Chain Reaction (PCR) Panels: Bacterial Vaginosis Polymerase Chain Reaction; Candida Species Polymerase Chain Reaction; Trichomoniasis Polymerase Chain Reaction; Mixed Vaginitis Polymerase Chain Reaction Panels; Aerobic Vaginitis Polymerase Chain Reaction; Atrophic Vaginitis Polymerase Chain Reaction
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company; Hologic Inc.; QIAGEN N.V.; ARUP Laboratories Inc.; Seegene Inc.; LetsGetChecked Ltd.; Sansure Biotech Inc.; Visby Medical Inc.; R-Biopharm AG; Savyon Diagnostics Ltd.; altona Diagnostics GmbH; SpeeDx Pty Ltd.; CERTEST BIOTEC S.L.; ALPCO Diagnostics; Atila Biosystems Inc.; Ridacom Diagnostics Ltd.; Sinochips Diagnostics Co Ltd.; Vitassay S.L.; Bioperfectus Technologies Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Characteristics

3. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Trends And Strategies

4. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Growth Rate Analysis
  • 5.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Total Addressable Market (TAM)

6. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Segmentation

  • 6.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels
  • Vaginitis Polymerase Chain Reaction (PCR) Panels
  • 6.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sexually Transmitted Infections
  • Vaginal Infections
  • 6.3. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Homecare Or At-Home Testing
  • Other End Users
  • 6.4. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chlamydia Trachomatis Polymerase Chain Reaction
  • Neisseria Gonorrhoeae Polymerase Chain Reaction
  • Trichomonas Vaginalis Polymerase Chain Reaction
  • Herpes Simplex Virus Polymerase Chain Reaction
  • Human Papillomavirus Polymerase Chain Reaction
  • Mycoplasma Genitalium Polymerase Chain Reaction
  • Syphilis Polymerase Chain Reaction
  • Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
  • 6.5. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Sub-Segmentation Of Vaginitis Polymerase Chain Reaction (PCR) Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Vaginosis Polymerase Chain Reaction
  • Candida Species Polymerase Chain Reaction
  • Trichomoniasis Polymerase Chain Reaction
  • Mixed Vaginitis Polymerase Chain Reaction Panels
  • Aerobic Vaginitis Polymerase Chain Reaction
  • Atrophic Vaginitis Polymerase Chain Reaction

7. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Regional And Country Analysis

  • 7.1. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 8.1. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 9.1. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 9.2. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 10.1. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 11.1. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 11.2. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 12.1. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 13.1. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 14.1. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 14.2. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 15.1. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 15.2. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 16.1. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 17.1. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 18.1. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 19.1. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 20.1. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 21.1. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 21.2. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 22.1. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 23.1. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 23.2. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 24.1. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 24.2. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 25.1. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 25.2. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 26.1. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 26.2. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 27.1. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 28.1. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 28.2. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

  • 29.1. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Overview
  • 29.2. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Landscape
  • 30.2. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Other Major And Innovative Companies

  • 31.1. Hologic Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. ARUP Laboratories Inc.
  • 31.4. Seegene Inc.
  • 31.5. LetsGetChecked Ltd.
  • 31.6. Sansure Biotech Inc.
  • 31.7. Visby Medical Inc.
  • 31.8. R-Biopharm AG
  • 31.9. Savyon Diagnostics Ltd.
  • 31.10. altona Diagnostics GmbH
  • 31.11. SpeeDx Pty Ltd.
  • 31.12. CERTEST BIOTEC S.L.
  • 31.13. ALPCO Diagnostics
  • 31.14. Atila Biosystems Inc.
  • 31.15. Ridacom Diagnostics Ltd.

32. Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

34. Recent Developments In The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market

35. Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer